Advertisement
Screener

Corvus Pharmaceuticals, Inc. (CRVS) Patents: Active

Corvus Pharmaceuticals, Inc. Active Patents

14 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2024-02-12: Application 18439695; Invention COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE; Applicant Corvus Pharmaceuticals, Inc.; Status Patented Case.
  • 2021-04-07: Application 17224410; Invention COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE; Applicant Corvus Pharmaceuticals, Inc.; Status Patented Case.
  • 2021-01-11: Application 17259303; Invention METHODS FOR DETECTING AND TREATING CANCERS HAVING ADENOSINE PATHWAY ACTIVATION; Applicant Corvus Pharmaceuticals, Inc.; Status Patented Case.
  • 2021-01-11: Application 17259298; Invention METHODS FOR DETECTING AND TREATING CANCERS HAVING ADENOSINE PATHWAY ACTIVATION; Applicant Corvus Pharmaceuticals, Inc.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2024-02-1218439695COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASECorvus Pharmaceuticals, Inc.Patented Case2026-07-2112686677US20240383884A1
Ryan Hudson
Anne- Marie Beausoleil
United States
United States
COLEMAN, BRENDA LIBBY
2021-04-0717224410COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASECorvus Pharmaceuticals, Inc.Patented Case2024-02-1311897874US20220363676A1
Ryan Hudson
Anne- Marie Beausoleil
United States
United States
COLEMAN, BRENDA LIBBY
2021-01-1117259303METHODS FOR DETECTING AND TREATING CANCERS HAVING ADENOSINE PATHWAY ACTIVATIONCorvus Pharmaceuticals, Inc.Patented Case2024-10-1512116635US20210254178A1
Stephen Willingham
Andrew Hotson
Richard A. Miller
United States
United States
United States
SWARTWOUT, BRIANNA KENDALL
2021-01-1117259298METHODS FOR DETECTING AND TREATING CANCERS HAVING ADENOSINE PATHWAY ACTIVATIONCorvus Pharmaceuticals, Inc.Patented Case2024-12-2412174192US20210255190A1
Stephen Willingham
Andrew Hotson
Richard A. Miller
United States
United States
United States
KIM, YOUNG J
2020-12-1717125596METHODS OF TREATING CANCERCorvus Pharmaceuticals, Inc.Patented Case2024-07-0212023337US20210154199A1
Stephen Willingham
Richard A. Miller
Po Y. Ho
Ian Mccaffery
Andrew Hotson
United States
United States
United States
United States
United States
LEE, WILLIAM Y
2020-08-2717005051ANTI-CD73 ANTIBODIESCORVUS PHARMACEUTICALS, INC.Patented Case2025-07-0812351644US20210221905A1
Emily Piccione Griffin
Richard A. Miller
Ian McCaffery
United States
United States
United States
HALVORSON, MARK
2020-07-2016963461PHARMACEUTICAL FORMULATIONSCorvus Pharmaceuticals, Inc.Patented Case2022-03-0811266649US20210060020A1
Jingrong Xu
William Jones
Felicia Flicker
Bret Berner
United States
United States
United States
United States
MERCIER, MELISSA S
2020-02-2016640508COMPOUNDS AND METHODS FOR MODULATING ADENOSINE A2B RECEPTOR AND ADENOSINE A2A RECEPTORCorvus Pharmaceuticals, Inc.Patented Case2022-02-2211254686
Zhihong Li
Lubov Konstantinovna Filonova
Erin Kathleen Bradley
Erik Verner
United States
United States
United States
United States
MURRAY, JEFFREY H
2019-10-0116500041METHODS OF TREATING CANCERCorvus Pharmaceuticals, Inc.Patented Case2021-06-2211040040US20200297728A1
Andrew Hotson
Richard A. Miller
Ian Mccaffery
Stephen Willingham
United States
United States
United States
United States
LEESER, ERICH A
2019-04-3016346360COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASECORVUS PHARMACEUTICALS, INC.Patented Case2021-05-1811008314US20190375743A1
Ryan HUDSON
Anne-Marie BEAUSOLEIL
United States
United States
COLEMAN, BRENDA LIBBY
2018-09-0716083409COMPOUNDS AND METHODS FOR MODULATING BRUTON'S TYROSINE KINASECORVUS PHARMACEUTICALS, INC.Patented Case2020-12-2210870652US20190106423A1
Ryan HUDSON
Anne-Marie BEAUSOLEIL
Richard A. MILLER
Erik VERNER
United States
United States
United States
United States
RAO, DEEPAK R
2018-06-2116065012METHODS OF TREATING CANCERCorvus Pharmaceuticals, Inc.Patented Case2021-02-0910912776US20190076433A1
Stephen Willingham
Richard A. Miller
Po Y. Ho
Ian McCaffery
Andrew Hotson
United States
United States
United States
United States
United States
LEE, WILLIAM Y
2018-03-3015942362PROCESSES FOR MAKING TRIAZOLO[4,5D] PYRAMIDINE DERIVATIVES AND INTERMEDIATES THEREOFCorvus Pharmaceuticals, Inc.Patented Case2020-05-1910654825US20180290999A1
Kolbot By
William Benton Jones
Bradley Hamilton Wolfe
United States
United States
United States
PAGANO, ALEXANDER R
2017-07-1115647212ANTI-CD73 ANTIBODIESCORVUS PHARMACEUTICALS, INC.Patented Case2020-10-0610793636US20180009899A1
Emily Piccione Griffin
Richard A. Miller
lan McCaffery
United States
United States
United States
RAWLINGS, STEPHEN L

Similar stocks

Stock NameCountryMarket CapPE Ratio
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Arbutus Biopharma Corp (ABUS)$0.965B6.19
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
Savara Inc (SVRA)United States$1.044B-9.10
Jade Biosciences, Inc. (JBIO)United States$0.936B-9.21
MANNKIND CORP (MNKD)United States$1.058B-30.41
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
Apnimed, Inc. (APMD)United States$0.899B